ArticleFrontiers in medicine2026
Automated follicle measurement and microvascular imaging accuracy in assessing diminished ovarian reserve via 3D ultrasound.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aimed to investigate the diagnostic values of automated follicle measurement and superb microvascular imaging using transvaginal three-dimensional (3D) ultrasound for diminished ovarian reserve (DOR) in women of reproductive age. Methods: This retrospective study included women who underwent ovarian reserve function assessment at the Affiliated Obstetrics and Gynecology Hospital of Tongji University between November 2022 and June 2023. The participants were categorized into the DOR and normal groups based on the anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) levels. Results: This study included 109 participants: 36 with diminished ovarian reserve (DOR) and 73 with normal ovarian function. Significant differences emerged between the groups in age, body mass index, AMH, FSH, the FSH/LH ratio, and estradiol (all Conclusion: This study identified AFC as the key predictor factor for DOR, with an AUC of 0.965 (95% CI: 0.902-0.993), demonstrating high diagnostic value. These results underscore the promising potential of transvaginal 3D ultrasound techniques to enhance the precision of ovarian reserve assessments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.